These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Market watch: industry perspectives on personalized medicine. Zuckerman R; Milne CP Nat Rev Drug Discov; 2012 Mar; 11(3):178. PubMed ID: 22378258 [No Abstract] [Full Text] [Related]
4. Market watch: Upcoming catalysts in Q1 2015. Uribe A Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330 [No Abstract] [Full Text] [Related]
5. Upcoming market catalysts in Q4 2009. Jatkoe L Nat Rev Drug Discov; 2009 Oct; 8(10):763. PubMed ID: 19794437 [No Abstract] [Full Text] [Related]
6. What makes a good forecaster? Earl J Nat Rev Drug Discov; 2003 Jan; 2(1):83. PubMed ID: 12521029 [No Abstract] [Full Text] [Related]
7. 25 top health care stocks. Will they lead the next market boom? Kane L Med Econ; 2001 Apr; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040 [No Abstract] [Full Text] [Related]
8. Trends in the market for antihypertensive drugs. Ali MA; Rizvi S; Syed BA Nat Rev Drug Discov; 2017 May; 16(5):309-310. PubMed ID: 28280260 [No Abstract] [Full Text] [Related]
9. Upcoming market catalysts in Q4 2019. Ranj T Nat Rev Drug Discov; 2019 Sep; 18(10):738. PubMed ID: 31570850 [No Abstract] [Full Text] [Related]
10. Drugs: budget busters or cost cutters in future health care? Egger E Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640 [No Abstract] [Full Text] [Related]
13. An audience with...Joseph Bolen. Interview by Bethan Hughes. Bolen J Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470 [TBL] [Abstract][Full Text] [Related]
14. DAKOTACARE update: how PhRMA is changing their approach to key generic launches, observations in the marketplace. Weiss D S D Med; 2013 Jun; 66(6):245-6. PubMed ID: 23923686 [No Abstract] [Full Text] [Related]
15. By the numbers. Suppliers/purchasing. Mod Healthc; 2007 Dec; Suppl():70, 72, 74 passim. PubMed ID: 18220137 [No Abstract] [Full Text] [Related]
16. An Audience with... Interview by Bethan Hughes. Chin W Nat Rev Drug Discov; 2010 May; 9(5):354. PubMed ID: 20431560 [No Abstract] [Full Text] [Related]
17. The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2. Becker ER; Morris DC; Culler SD; Mauldin PD; Shaw LJ; Talley JD; Weintraub WS Am J Manag Care; 1999 Sep; 5(9):1125-30. PubMed ID: 10621078 [TBL] [Abstract][Full Text] [Related]
18. Neurology and medical devices. Johnston SC; Hauser SL Ann Neurol; 2006 Oct; 60(4):11A-2A. PubMed ID: 17068793 [No Abstract] [Full Text] [Related]
19. Health care lobbying: time to make patients the special interest. Kushel M; Bindman AB Am J Med; 2004 Apr; 116(7):496-7. PubMed ID: 15047042 [No Abstract] [Full Text] [Related]
20. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim. Jungbauer A; Göbel U Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694 [No Abstract] [Full Text] [Related] [Next] [New Search]